| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 22,259 | 12,916 | | Cost of Revenue | 4,105 | 2,625 | | | Gross Profit | 18,154 | 10,291 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 6,623 | 11,714 | | Non Recurring | 31,989 |
-
| | Others | 1,554 |
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (22,012) | (1,423) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (4,273) |
-
| | Earnings Before Interest And Taxes | (26,285) | (1,423) | | Interest Expense | 4,521 | 134 | | Income Before Tax | (30,806) | (1,557) | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (30,806) | (1,557) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (30,806) | (1,557) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($30,806) | ($1,557) |
|
0.34% Nasdaq 
Income Statement
